RxDoctor Payments Data

Tracy Sweat

Medical · McPherson, KSNPI 1871557272

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 410 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,522 and has fallen 70.8% since, to $444 in 2025. Among medical clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,882in general payments, 2019–2025

Across 410 payments — averaging $14.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$813
  • Amgen$725
  • Pfizer$650
  • AstraZeneca$450
  • Novo Nordisk$435
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$5,869100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,882 in reported general payments places this provider in the 90th percentile of 205 medical providers in Kansas.

See all medical providers in Kansas

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin34$34,031
EliquisApixaban27$19,484
RybelsusSemaglutide14$17,742
MounjaroTirzepatide15$14,138
MyrbetriqMirabegron23$10,058
GemtesaVibegron11$4,731
Esomeprazole Magnesium15$939
SynthroidLevothyroxine Sodium12$927
Olmesartan Medoxomil30$868
Metoprolol Succinate50$852
Gabapentin92$783
Levothyroxine Sodium116$646
Potassium Chloride20$597
Escitalopram Oxalate42$528
Amlodipine Besylate112$506

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$64$34,03134 claims
PfizerEliquis$650$19,48427 claims
Novo NordiskRybelsus$435$17,74214 claims
Lilly USA, LLCMounjaro$813$14,13815 claims
Astellas Pharma US IncMyrbetriq$27$10,05823 claims
Sumitomo Pharma America, Inc.Gemtesa$89$4,73111 claims
AbbVieSynthroid$1,098$92712 claims
Teva Pharmaceuticals USA, Inc.Acyclovir$14$13815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 205 medical providers in Kansas.

Other medical in McPherson

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →